Alimera Sciences, Inc. (ALIM)
ALIM moved a median of 0.00% 30 minutes after news, and 0.00% by the close. How ALIM actually reacts to news — the realized, point-in-time move the market made, measured across 144 labeled events over the last three years with zero look-ahead.
ALIM’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 38% | 69 |
| 30-min | 0.00% | 41% | 86 |
| 60-min | +0.04% | 50% | 100 |
| to close | 0.00% | 42% | 102 |
| Middle 50% of ALIM reactions | -0.29% to +0.53% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 144 |
Half of all Alimera Sciences, Inc. news events land between -0.29% and +0.53% at 30 minutes.
Reaction stats as of 2026-08-31. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How ALIM reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst downgrades | 10 | -0.09% | 30% | -0.36% |
| Coverage initiations | 22 | +0.04% | 50% | -0.18% |
Last 3 years, pulled 2026-08-31. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 1 further class was observed with fewer than 10 measured events and is not published. See how ALIM ranks against every other measured name →
That’s how ALIM usually reacts — get an email when it moves on news →Email me when ALIM moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to ALIM's baseline. Nothing else.
Recent ALIM events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 15-12G ALIMERA SCIENCES INC | SEC filing · Form 15-12G | SEC EDGAR | — | — | |
| Form EFFECT ALIMERA SCIENCES INC | SEC filing · Form EFFECT | SEC EDGAR | — | — | |
| Form 8-K ALIMERA SCIENCES INC For: Sep 16 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Form POS AM ALIMERA SCIENCES INC | SEC filing · Form POS | SEC EDGAR | — | — | |
| Form S-8 POS ALIMERA SCIENCES INC | SEC filing · Form S-8 | SEC EDGAR | — | — | |
| ANI Pharmaceuticals and Alimera Sciences Announce Closing Date of Merger | Press release | Business Wire | -0.09% | +0.00% | |
| Form 8-K ALIMERA SCIENCES INC For: Sep 11 | SEC filing · Form 8-K | SEC EDGAR | -0.09% | +0.00% | |
| Alimera Sciences Takes Legal Action Against ANI Pharmaceuticals to Enforce Merger Agreement | Press release | Business Wire | -1.29% | +11.37% | |
| Form 8-K ALIMERA SCIENCES INC For: Sep 04 | SEC filing · Form 8-K | SEC EDGAR | -0.09% | +0.00% | |
| Form 8-K ALIMERA SCIENCES INC For: Sep 10 | SEC filing · Form 8-K | SEC EDGAR | -1.29% | +11.37% | |
| Form DEFM14A ALIMERA SCIENCES INC | SEC filing · Form DEFM14A | SEC EDGAR | -0.27% | +0.18% | |
| Form 10-Q ALIMERA SCIENCES INC For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | +0.36% | |
| Alimera Sciences Reports Second Quarter 2024 Results | Press release | GlobeNewswire | +0.18% | +0.18% | |
| Form 8-K ALIMERA SCIENCES INC For: Aug 06 | SEC filing · Form 8-K | SEC EDGAR | +0.18% | +0.18% | |
| Form PREM14A ALIMERA SCIENCES INC For: Jul 24 | SEC filing · Form PREM14A | SEC EDGAR | +0.00% | +0.00% | |
| Form 8-K ALIMERA SCIENCES INC For: Jul 17 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.18% | |
| BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Alimera Sciences, Inc. (Nasdaq - ALIM), Avangrid, Inc. (NYSE - AGR), PlayAGS, Incorporated (NYSE - AGS), RBAZ Bancorp, Inc. (OTCPK - RBAZ) | Press release | GlobeNewswire | -0.09% | -0.27% | |
| BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Alimera Sciences, Inc. (Nasdaq - ALIM), Avangrid, Inc. (NYSE - AGR), SilverBow Resources, Inc. (NYSE - SBOW), Reneo Pharmaceuticals, Inc. (Nasdaq - RPHM) | Press release | GlobeNewswire | +0.09% | -0.54% | |
| ALIM Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Alimera Sciences to ANI Pharmaceuticals | Press release | GlobeNewswire | +0.27% | -0.18% | |
| ALIM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Alimera Sciences, Inc. Is Fair to Shareholders | Press release | Business Wire | +0.27% | -0.18% | |
| Form 8-K ALIMERA SCIENCES INC For: Jun 19 | SEC filing · Form 8-K | SEC EDGAR | +0.27% | -0.18% | |
| Form 8-K ALIMERA SCIENCES INC For: Jun 21 | SEC filing · Form 8-K | SEC EDGAR | +0.27% | -0.18% | |
| Alimera Sciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Press release | GlobeNewswire | — | -3.54% | |
| Alimera Sciences Reports First Quarter 2024 Results | Press release | GlobeNewswire | -4.41% | -3.53% | |
| Form 10-Q ALIMERA SCIENCES INC For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.92% | -0.30% | |
| Form 8-K ALIMERA SCIENCES INC For: May 14 | SEC filing · Form 8-K | SEC EDGAR | -4.41% | -3.53% | |
| Alimera Announces Scientific Data Highlighting YUTIQ® to be Presented at Upcoming Association for Research in Vision and Ophthalmology and Retina World Congress Conferences | Press release | GlobeNewswire | +0.00% | -0.83% | |
| Alimera Sciences to Report First Quarter 2024 Financial Results on May 14, 2024, and Provide Corporate Update | Press release | GlobeNewswire | — | +1.66% | |
| Form 10-K/A ALIMERA SCIENCES INC For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | — | +1.66% | |
| Alimera Sciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Press release | GlobeNewswire | +0.00% | -3.95% | |
| Alimera Announces First Patient Randomized in Radiation Retinopathy Trial Being Conducted by the DRCR Retina Network | Press release | GlobeNewswire | -0.25% | +1.00% | |
| Form 10-K ALIMERA SCIENCES INC For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | -2.77% | -5.04% | |
| Form S-8 ALIMERA SCIENCES INC | SEC filing · Form S-8 | SEC EDGAR | -2.77% | -5.04% | |
| Alimera Sciences Reports Fourth Quarter and Full Year 2023 Results | Press release | GlobeNewswire | +6.82% | +2.36% | |
| Form 8-K ALIMERA SCIENCES INC For: Mar 06 | SEC filing · Form 8-K | SEC EDGAR | +6.82% | +2.36% | |
| Alimera Sciences to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024, and Provide Corporate Update | Press release | GlobeNewswire | -1.47% | +4.12% | |
| Form 8-K ALIMERA SCIENCES INC For: Feb 08 | SEC filing · Form 8-K | SEC EDGAR | +6.07% | +1.05% | |
| Form S-8 ALIMERA SCIENCES INC | SEC filing · Form S-8 | SEC EDGAR | +6.07% | +1.05% | |
| The UK National Institute for Health and Care Excellence (NICE) Issues Final Draft Guidance to Provide Patients with a Natural Lens (Phakic Eye) Being Treated for Chronic Diabetic Macular Edema Access to ILUVIEN® | Press release | GlobeNewswire | +2.53% | -1.52% | |
| Alimera Completes Recruitment for the Synchronicity Study | Press release | GlobeNewswire | +0.00% | +2.44% | |
| Form 8-K ALIMERA SCIENCES INC For: Dec 28 | SEC filing · Form 8-K | SEC EDGAR | -4.44% | -3.95% | |
| Alimera Sciences Names Elliot Maltz as Chief Financial Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | Press release | GlobeNewswire | -0.46% | -6.85% | |
| Alimera Sciences Appoints Todd Wood as President of U.S. Operations and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | Press release | GlobeNewswire | — | +0.81% | |
| Form 8-K ALIMERA SCIENCES INC For: Dec 11 | SEC filing · Form 8-K | SEC EDGAR | — | -0.79% | |
| Alimera Appoints Maggie A. Pax to Its Board of Directors | Press release | GlobeNewswire | — | +0.29% | |
| Form 8-K ALIMERA SCIENCES INC For: Nov 07 | SEC filing · Form 8-K | SEC EDGAR | — | +0.29% | |
| Form 10-Q ALIMERA SCIENCES INC For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | — | +0.31% | |
| Alimera Announces Scientific Data Highlighting ILUVIEN® To Be Presented at the American Academy of Ophthalmology | Press release | GlobeNewswire | -6.95% | -0.89% | |
| Alimera Sciences Reports Third Quarter 2023 Results | Press release | GlobeNewswire | -0.99% | +7.07% | |
| Form 8-K ALIMERA SCIENCES INC For: Oct 26 | SEC filing · Form 8-K | SEC EDGAR | -0.99% | +7.07% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the ALIM section they belong to.
Where else ALIM is measured.
ALIM earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Mustang Bio, Inc. (MBIO) | 145 | -0.44% | 41% |
| Redhill Biopharma Ltd. - American Depositary Shares (RDHL) | 145 | -0.38% | 42% |
| BeyondSpring, Inc. - Ordinary Shares (BYSI) | 144 | 0.00% | 50% |
| Cara Therapeutics, Inc. (CARA) | 144 | -0.53% | 46% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Alimera Sciences, Inc.'s median reaction calculated?
Every labeled ALIM news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 144 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 41% of ALIM's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-08-31.
Does ALIM's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.